MX158152A - Procedimiento para preparar pirrolidina-2,5-diona espirocondensadas - Google Patents
Procedimiento para preparar pirrolidina-2,5-diona espirocondensadasInfo
- Publication number
- MX158152A MX158152A MX203915A MX20391584A MX158152A MX 158152 A MX158152 A MX 158152A MX 203915 A MX203915 A MX 203915A MX 20391584 A MX20391584 A MX 20391584A MX 158152 A MX158152 A MX 158152A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrrolidine
- formula
- independently represent
- lower alkyl
- spyrocondensated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58245799A JPS60142984A (ja) | 1983-12-28 | 1983-12-28 | 新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX158152A true MX158152A (es) | 1989-01-11 |
Family
ID=17139003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX203915A MX158152A (es) | 1983-12-28 | 1984-12-28 | Procedimiento para preparar pirrolidina-2,5-diona espirocondensadas |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4593092A (es) |
| EP (1) | EP0147805B1 (es) |
| JP (1) | JPS60142984A (es) |
| KR (1) | KR900004589B1 (es) |
| AT (1) | ATE57382T1 (es) |
| AU (1) | AU568709B2 (es) |
| CA (1) | CA1254559A (es) |
| DE (1) | DE3483391D1 (es) |
| DK (1) | DK615984A (es) |
| ES (2) | ES8606353A1 (es) |
| HU (1) | HU191740B (es) |
| MX (1) | MX158152A (es) |
| PH (1) | PH21187A (es) |
| PT (1) | PT79759A (es) |
| ZA (1) | ZA849931B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6317886A (ja) * | 1986-07-11 | 1988-01-25 | Kyorin Pharmaceut Co Ltd | スピロピロリジン−２，５−ジオン誘導体の製法 |
| US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
| US5300642A (en) * | 1986-04-10 | 1994-04-05 | The Du Pont Merck Pharmaceutical Company | α, α-disubstituted aromatics and heteroaromatics as cognition enhancers |
| JPS6317885A (ja) * | 1986-07-11 | 1988-01-25 | Kyorin Pharmaceut Co Ltd | スピロピロリジン−２，５−ジオン誘導体の製造方法 |
| US5434264A (en) * | 1988-08-23 | 1995-07-18 | The Du Pont Merck Pharmaceutical Company | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
| US4900739A (en) * | 1988-10-20 | 1990-02-13 | American Home Products Corp. | Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents |
| US4946858A (en) * | 1988-10-20 | 1990-08-07 | American Home Products Corporation | Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents |
| TW202450B (es) * | 1991-06-26 | 1993-03-21 | Dainippon Pharmaceutical Co | |
| US7510851B2 (en) * | 2001-12-17 | 2009-03-31 | Metabolex, Inc. | Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia |
| AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| AR056968A1 (es) | 2005-04-11 | 2007-11-07 | Xenon Pharmaceuticals Inc | Compuestos espiro-oxindol y composiciones farmacéuticas |
| MX2009003874A (es) * | 2006-10-12 | 2009-04-22 | Xenon Pharmaceuticals Inc | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. |
| MX2009003876A (es) | 2006-10-12 | 2009-05-11 | Xenon Pharmaceuticals Inc | Uso de compuestos de espiro-oxindol como agentes terapeuticos. |
| KR101286323B1 (ko) | 2008-10-17 | 2013-07-15 | 제논 파마슈티칼스 인크. | 스피로-옥스인돌 화합물 및 치료제로서의 그의 용도 |
| CA2741024A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| MY165579A (en) | 2009-10-14 | 2018-04-05 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
| CN105726531A (zh) | 2010-02-26 | 2016-07-06 | 泽农医药公司 | 用于局部给药的螺-羟吲哚化合物的药物组合物及其作为治疗剂的用途 |
| WO2016127068A1 (en) | 2015-02-05 | 2016-08-11 | Teva Pharmaceuticals International Gmbh | Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193996A (en) * | 1979-04-04 | 1980-03-18 | Pfizer Inc. | Spiro-quinolone hydantoins |
| IE53102B1 (en) * | 1981-05-12 | 1988-06-22 | Ici Plc | Pharmaceutical spiro-succinimide derivatives |
| EP0065392B1 (en) * | 1981-05-13 | 1985-02-13 | Imperial Chemical Industries Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
-
1983
- 1983-12-28 JP JP58245799A patent/JPS60142984A/ja active Granted
-
1984
- 1984-12-19 CA CA000470547A patent/CA1254559A/en not_active Expired
- 1984-12-20 DK DK615984A patent/DK615984A/da not_active Application Discontinuation
- 1984-12-20 EP EP84115973A patent/EP0147805B1/en not_active Expired - Lifetime
- 1984-12-20 DE DE8484115973T patent/DE3483391D1/de not_active Expired - Lifetime
- 1984-12-20 AT AT84115973T patent/ATE57382T1/de not_active IP Right Cessation
- 1984-12-20 ZA ZA849931A patent/ZA849931B/xx unknown
- 1984-12-24 US US06/685,804 patent/US4593092A/en not_active Expired - Fee Related
- 1984-12-27 PT PT79759A patent/PT79759A/pt not_active IP Right Cessation
- 1984-12-28 ES ES539208A patent/ES8606353A1/es not_active Expired
- 1984-12-28 HU HU844874A patent/HU191740B/hu not_active IP Right Cessation
- 1984-12-28 MX MX203915A patent/MX158152A/es unknown
- 1984-12-28 KR KR1019840008499A patent/KR900004589B1/ko not_active IP Right Cessation
- 1984-12-28 AU AU37199/84A patent/AU568709B2/en not_active Ceased
- 1984-12-28 PH PH31667A patent/PH21187A/en unknown
-
1985
- 1985-12-16 ES ES549979A patent/ES8702914A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| HU191740B (en) | 1987-04-28 |
| DE3483391D1 (de) | 1990-11-15 |
| DK615984A (da) | 1985-06-29 |
| ES8702914A1 (es) | 1987-01-16 |
| PT79759A (en) | 1985-01-01 |
| KR900004589B1 (ko) | 1990-06-30 |
| EP0147805A3 (en) | 1986-07-09 |
| ES539208A0 (es) | 1986-04-01 |
| EP0147805B1 (en) | 1990-10-10 |
| JPH0370708B2 (es) | 1991-11-08 |
| AU3719984A (en) | 1985-07-04 |
| AU568709B2 (en) | 1988-01-07 |
| ES8606353A1 (es) | 1986-04-01 |
| DK615984D0 (da) | 1984-12-20 |
| EP0147805A2 (en) | 1985-07-10 |
| ES549979A0 (es) | 1987-01-16 |
| ATE57382T1 (de) | 1990-10-15 |
| JPS60142984A (ja) | 1985-07-29 |
| US4593092A (en) | 1986-06-03 |
| CA1254559A (en) | 1989-05-23 |
| ZA849931B (en) | 1985-08-28 |
| HUT37433A (en) | 1985-12-28 |
| KR850004769A (ko) | 1985-07-27 |
| PH21187A (en) | 1987-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX158152A (es) | Procedimiento para preparar pirrolidina-2,5-diona espirocondensadas | |
| FI900461A0 (fi) | Imidazopyridaziner, deras framstaellning och anvaendning. | |
| DK0430201T3 (es) | ||
| DE69128302D1 (de) | Spiro-isochinolin-pyrrolidine und Analoge davon zur Verwendung als Aldose-Reduktase-Hemmer | |
| ES2012648A6 (es) | Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina. | |
| ATE207058T1 (de) | Amine derivate, ihre herstellung und anwendung | |
| FI915875A (fi) | Menetelmä yleisen kaavan I mukaisten lääkeaineina käyttökelpoisten 2,3-dihydro-4H-1,3-bentsoksatsinon-4-onien ja 2,3-dihydro-4H-bentsotiatsinon-4-onien nitro-oksijohdannaisten valmistamiseksi | |
| NO894384L (no) | Forbindelser for behandling av urininkontinens. | |
| FI912499A0 (fi) | Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ES552874A0 (es) | Un procedimiento para preparar benzo (c)-1,5-naftiridinas |